Log in

Relevant bibliographies by topics / Decan / Journal articles

Journal articles on the topic 'Decan'

To see the other types of publications on this topic, follow the link: Decan.

Author: Grafiati

Published: 26 July 2024

Last updated: 27 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Decan.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Aitken, R., Neil Keddie, and Alexandra Slawin. "3,5-Dithiatricyclo[5.2.1.02,6]decan-4-one." Molbank 2020, no. 2 (April 24, 2020): M1126. http://dx.doi.org/10.3390/m1126.

Full text

Abstract:

The X-ray structure of the title compound has been determined and the structure shows an exo-configured planar dithiolanone ring. This is in contrast to the few previous dithiolanones to be characterised crystallographically, which are all twisted.

APA, Harvard, Vancouver, ISO, and other styles

2

Graham, David B., Alexander L. Eastman, Kim N. Aldy, Elizabeth A. Carroll, Joseph P. Minei, Scott C. Brakenridge, and Herb A. Phelan. "Outcomes and Long Term Follow-up after Emergent Cricothyroidotomy: Is Routine Conversion to Tracheostomy Necessary?" American Surgeon 77, no. 12 (December 2011): 1707–11. http://dx.doi.org/10.1177/000313481107701248.

Full text

Abstract:

The purpose of this study is to identify factors associated with survival after cricothyroidotomy (CRIC), and to ascertain long-term outcomes in patients simply decannulated after CRIC versus those revised to tracheostomy. All CRICs between October 1, 1995 and June 20, 2010 were reviewed. Patients were contacted by phone, visited at their last known address, or queried in the Center for Disease Control's National Death Index. DECAN were those CRICs decannulated without revision. TRACH were those revised to a tracheostomy at any point. Ninety-five CRIC patients were identified. In 94 per cent of survivors of initial admission, a Glasgow Coma Score (GCS) of 15 was noted at disposition. Cardiopulmonary resuscitation before or during CRIC performance was strongly associated with all-cause death during index admission, and increasing head Abbreviated Injury Score was associated with lower odds of a neurologically intact survival. Of survivors, 82 per cent of DECAN and 57 per cent of TRACH patients were followed-up with at medians of 48 (interquartile range 19-57) and 53 (20-119) months, respectively. DECAN occurred at a median of 4 days (2-7) whereas TRACH revision occurred at a median of 2 days (1-7). Endoscopy was performed on 36 per cent of DECAN patients and 22 per cent of TRACH patients. Two DECAN patients with acute subglottic edema/stenosis decannulated successfully on days 9 and 15 postinjury and had no problems at 54 and 91 months postinjury. At follow-up, no patient in either group had suffered a clinically evident airway complication. The need for cardiopulmonary resuscitation before or during CRIC portends poorly for neurologically intact survival. Simple decannulation is appropriate for CRIC patients when their need for airway protection has resolved.

APA, Harvard, Vancouver, ISO, and other styles

3

Polat, İlknur, Selçuk Eşsiz, Uğur Bozkaya, and Emine Salamci. "Efficient and regioselective synthesis of dihydroxy-substituted 2-aminocyclooctane-1-carboxylic acid and its bicyclic derivatives." Beilstein Journal of Organic Chemistry 18 (January 6, 2022): 77–85. http://dx.doi.org/10.3762/bjoc.18.7.

Full text

Abstract:

The first synthesis of 2-amino-3,4-dihydroxycyclooctane-1-carboxylic acid, methyl 6-hydroxy-9-oxo-8-oxabicyclo[5.2.1]decan-10-yl)carbamate, and 10-amino-6-hydroxy-8-oxabicyclo[5.2.1]decan-9-one starting from cis-9-azabicyclo[6.2.0]dec-6-en-10-one is described. cis-9-Azabicyclo[6.2.0]dec-6-en-10-one was transformed into the corresponding amino ester and its protected amine. Oxidation of the double bond in the N-Boc-protected methyl 2-aminocyclooct-3-ene-1-carboxylate then delivered the targeted amino acid and its derivatives. Density-functional theory (DFT) computations were used to explain the reaction mechanism for the ring opening of the epoxide and the formation of five-membered lactones. The stereochemistry of the synthesized compounds was determined by 1D and 2D NMR spectroscopy. The configuration of methyl 6-hydroxy-9-oxo-8-oxabicyclo[5.2.1]decan-10-yl)carbamate was confirmed by X-ray diffraction.

APA, Harvard, Vancouver, ISO, and other styles

4

Totchasov, E. D., M. Yu Nikiforov, and G. A. Al’per. "Heat capacity calculations for the decan-1-ol-n-decane system from viscosity data." Russian Journal of Physical Chemistry A 81, no. 8 (August 2007): 1346–48. http://dx.doi.org/10.1134/s0036024407080304.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Polunkin, Ie V., V. S. Pilyavsky, T. M. Kamenieva, S. L. Melnykova, О. О. Gajdaj, and Yu I. Bogomolov. "Temperature inversion of the action of multilayer fullerenoid structures in the oxidation of N-decan by molecular oxygen." Catalysis and Petrochemistry, no. 32 (2021): 99–105. http://dx.doi.org/10.15407/kataliz2021.32.099.

Full text

Abstract:

It was established that at low temperatures MFS inhibit the oxidation of n-decan, and at temperatures close to the boiling point of the hydrocarbon, on the contrary, accelerate the transformation of the original alkane molecules. The composition of alkane transformation products in the high-temperature two-phase (gas-liquid) oxidation regime was analyzed by gas-liquid chromatography. It is shown that the transformation of n-decan molecules occurs according to the same schemes both in the case of oxidation without the additive of MFS, and in the presence of these compounds in a liquid. The work is devoted to the actual problem of increasing the energy efficiency of liquid motor fuels (gasoline, diesel and jet fuels) in transport power plants. One of the most acceptable ways to solve this problem at the present stage, which does not require capital expenditure, is to improve the processes of chemical transformations of fuel molecules in engines under the action of additives. The use of multilayer fullerene-like structures (MFS) as additives to motor fuels is proposed. The influence of additives modified MFS on the conversion of reagents in the processes of liquid-phase oxidation of n-decan by molecular oxygen at low (70°C) and high (150°C) temperatures has been studied. The change in the direction of the MFS action on chemical transformation of initial reagents depending on process temperature is experimentally revealed. It was established that at low temperatures MFS inhibit the oxidation of n-decan, and at temperatures close to the boiling point of hydrocarbons, on the contrary, accelerate the transformation of the original alkane molecules. The composition of alkane transformation products at high-temperature two-phase (gas-liquid) oxidation regime was analyzed by gas-liquid chromatography. It is shown that the transformation of n-decan molecules occurs according to the same schemes both in the case of oxidation without the additive of MFS, and in the presence of these compounds in a liquid.

APA, Harvard, Vancouver, ISO, and other styles

6

Jänchen, Jochen, and Helmut Stoch. "Isostere Adsorptionsuntersuchungen von n-Decan an Silicalit." Zeitschrift für Chemie 24, no. 4 (August 31, 2010): 158–59. http://dx.doi.org/10.1002/zfch.19840240435.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Krech, F., K. Issleib, A. Zschunke, and H. Meyer. "Cis- und trans-1-Phosphabicyclo[4.4.0]decan." Zeitschrift f�r anorganische und allgemeine Chemie 553, no. 10 (October 1987): 136–46. http://dx.doi.org/10.1002/zaac.19875531016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Ha, Kwang. "Crystal structure of 2-(tricyclo[3.3.1.13,7]decan-1-yl)-3-(tricyclo[3.3.1.13,7]- decan-1-ylimino)isoindolin-1-one, C28H34N2O." Zeitschrift für Kristallographie - New Crystal Structures 228, no. 1 (March 1, 2013): 107–8. http://dx.doi.org/10.1524/ncrs.2013.0070.

Full text

Abstract:

Abstract C28H34N2O, triclinic, P1̄ (no. 2), a = 6.604(1) Å, b = 11.680(2) Å, c = 15.286(3) Å, α = 70.242(4)°, β = 87.390(4)°, γ = 81.377(4)°, V = 1097.1 Å3, Z = 2, Rgt(F) = 0.0546, wRref(F2) = 0.1604, T = 200 K.

APA, Harvard, Vancouver, ISO, and other styles

9

Ma, Yuguo, Emil B. Lobkovsky, and Geoffrey W. Coates. "Titanium(iv) catalysts with ancillary imino-spiroketonato ligands: synthesis, structure and olefin polymerization." Dalton Transactions 44, no. 27 (2015): 12265–72. http://dx.doi.org/10.1039/c5dt01104c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hu, Gang, Chu Wang, Xin Xin, Shuaikang Li, Zefei Li, Yanfang Zhao, and Ping Gong. "Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine derivatives as potent antitumor agents." New Journal of Chemistry 43, no. 25 (2019): 10190–202. http://dx.doi.org/10.1039/c9nj02154j.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Kumaran, M. K., and George C. Benson. "Excess volumes of (decan-1-ol + 2,2,3-trimethylbutane)." Journal of Chemical Thermodynamics 17, no. 7 (July 1985): 699–700. http://dx.doi.org/10.1016/0021-9614(85)90125-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Patel, Parth P., Navin B. Patel, Manesh S. Tople, Vatsal M. Patel, and Dhanji P. Rajani. "Microwave-Assisted Synthesis of 2-(Arylidene)-1-thia-4-azaspiro[4.5]decan-3-ones and their Antibacterial, Antitubercular, and In Silico Screening." INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 33, no. 03 (September 30, 2023): 285. http://dx.doi.org/10.59467/ijhc.2023.33.285.

Full text

Abstract:

2-(Arylidene)-1-thia-4-azaspiro[4.5]decan-3-ones (3a-e, 4a-e) were synthesized from the 1-thia-4-azaspiro[4.5] decan-3-one through Knoevenagel reaction using the microwave method. In vitro, antibacterial and antitubercular screening of synthetic derivatives 3a-e and 4a-e revealed that compounds 3a and 4b are considerably potent as antibacterial agents against Escherichia coli with MIC = 50 μg/mL and MIC = 50 μg/mL, respectively. Compounds 3e and 4e possessed very good antitubercular activity with MIC = 0.47 μg/mL and MIC = 0.43 μg/mL. The results of molecular docking analysis supported the results of in vitro evaluation as against antibacterial protein compound 3a showed the lowest binding energy and against antitubercular protein, while 3e and 4e were highly attached?

APA, Harvard, Vancouver, ISO, and other styles

13

Takemura, Tetsuo, Yoshiko Hosoya, and Nobuo Mori. "The substrate- and stereoselectivity of microbial reductions of 1,4-dithiaspiro[4.5]decanones and 1,5-dithiaspiro[5.5]undecanones." Canadian Journal of Chemistry 68, no. 4 (April 1, 1990): 523–29. http://dx.doi.org/10.1139/v90-080.

Full text

Abstract:

The title spirocyclic ketones, possessing possible substitution patterns 1,4-dithiaspiro[4.5]decan-6-one (1a), -7-one (3a), and -8-one (5a), and 1,5-dithiaspiro[5.5]undecan-7-one (2a), -8-one (4a), and -9-one (6a), have been reduced with new strains of yeast (Saccharomycescerevisiae, JCM 1819 and JCM 2214). Reductions of the prochiral ketones 1a–4a occur with high enantiofacial selectivity on the preparative scale (up to 99% ee). The product alcohols (1,4-dithiaspiro[4.5]decan-6-ol (1b) and -7-ol (3b) and 1,5-dithiaspiro[5.5]undecan-7-ol (2b) and -8-ol (4b)) have the S configuration, as confirmed by 2D COSY experiments of the (S)-MTPA esters of 1b–4b using the configuration correlation model of Mosher. Keywords: microbial reduction, Saccharomycescerevisiae, dithiaspiro ketones, substrate- and stereoselectivity, H,H-COSY spectra.

APA, Harvard, Vancouver, ISO, and other styles

14

Singh, Raj Bahadur, Krishna Srivastava, Ram Prakash Tiwari, and Jyoti Srivastava. "Synthesis of Novel Oxazin Analogs of Thio-4-azaspiro[4.5]decan-3-one for their Antimicrobial Activity." Asian Journal of Organic & Medicinal Chemistry 6, no. 2 (2021): 116–20. http://dx.doi.org/10.14233/ajomc.2021.ajomc-p323.

Full text

Abstract:

The present work reports the synthesis of 4-(1-(substituted phenyl)-1H-naphtho[1,2-e][1,3]oxazin- 2(3H)-yl)-1-thia-4-azaspiro-[4.5]-decan-3-one IV(a-h) by 4-(((substituted phenyl)(2-hydroxynaphthalen- 1-yl) ethyl)amino)-1-thia-4-azaspiro[4.5]decan-3-one with formaldehyde in acetonitrile, containing a spiro ring obtained from the reaction of cyclohexylidene hydrazine and thioglycollic acid in DMF (cyclohexanone reacts with hydrazine hydrate in pyridine). The structures of the synthesized compounds have been established on the basis of elemental analysis, UV-vis absorption spectroscopy, IR, 1H NMR and mass spectral studies. The in vitro antimicrobial screening of all novel compounds was done against S. aureus, E. coli, P. aeruginosa and B. subtilis. The activity of compounds IVb, IVc, IVe and IVf compounds showed moderate to good activity against the tested microbes.

APA, Harvard, Vancouver, ISO, and other styles

15

Abraham, Michael H., Joelle le, and William E. Acree. "The Solvation Properties of the Aliphatic Alcohols." Collection of Czechoslovak Chemical Communications 64, no. 11 (1999): 1748–60. http://dx.doi.org/10.1135/cccc19991748.

Full text

Abstract:

Solubilities of solute gases and vapours, as log L, where L is the Ostwald solubility coefficient, in the alkan-1-ols from methanol to decan-1-ol have been correlated through the solvation equation of Abraham. It is shown that there is a regular progression of solvent properties from methanol to decan-1-ol, except for the solvent hydrogen-bond basicity that remains the same along the series, and, indeed, is the same as that of water. A slightly different solvation equation is used to correlate the partition of solutes from water to the dry alkanols. For the longer chain alkanols, the coefficients in the solvation equations approach those in equations for partition from water to the wet (water-saturated) alkanols, showing that the solvation properties of the wet and dry alkanols are quite close for the higher alkanol homologues.

APA, Harvard, Vancouver, ISO, and other styles

16

Hřebabecký, Hubert, Martin Dračínský, Armando M. De Palma, Johan Neyts, and Antonín Holý. "Synthesis of novel racemic carbocyclic nucleoside analogues derived from 4,8-dioxatricyclo[4.2.1.03,7]nonane-9-methanol and 4-oxatricyclo[4.3.1.03,7]decane-10-methanol, compounds with activity against Coxsackie viruses." Collection of Czechoslovak Chemical Communications 74, no. 3 (2009): 469–85. http://dx.doi.org/10.1135/cccc2008193.

Full text

Abstract:

(1R*,2R*,3R*,4S*)-7-Oxabicyclo[2.2.1]hept-5-ene-2,3-dimethanol (10) and (1R*,2R*,3R*,4S*)-bicyclo[2.2.2]oct-5-ene-2,3-dimethanol (14), which were prepared by the Diels–Alder reaction and subsequent reduction with lithium aluminium hydride, were treated with benzyl azidoformate to give benzylN-[(1R*,2R*,3S*,6S*,7S*,9S*)-9-(hydroxymethyl)-4,8-dioxatricyclo[4.2.1.03,7]nonan-2-yl]carbamate (11) and benzylN-[(1R*,2R*,3R*,6R*,7S*,10S*)-10-(hydroxymethyl)-4-oxatricyclo[4.3.1.03,7]decan-2-yl]carbamate (15). Hydrogenolysis of carbamates11or15afforded (1R*,2R*,3S*,6S*,7S*,9S*)-2-amino-4,8-dioxatricyclo[4.2.1.03,7]nonane-9-methanol (12) or (1R*,2R*,3R*,6R*,7S*,10S*)-2-amino-4-oxatricyclo[4.3.1.03,7]decane-10-methanol (16). The amines12and16were transformed to thymine and purine nucleoside analogues. The target compounds were tested for the activity againstCoxsackievirus.

APA, Harvard, Vancouver, ISO, and other styles

17

Udvardy, Antal, Ágnes Kathó, Gábor Papp, Ferenc Joó, and Gyula Tamás Gál. "Novel three-dimensional coordination polymer of 2-(1,3,5-triaza-7-phosphoniatricyclo[3.3.1.1^3,7]decan-7-yl)ethanoic acid with silver(I) tetrafluoroborate." Acta Crystallographica Section E Crystallographic Communications 78, no. 3 (February 1, 2022): 251–54. http://dx.doi.org/10.1107/s2056989022000767.

Full text

Abstract:

An AgI-based coordination polymer (CP), namely, poly[[[μ3-2-(1,3,5-triaza-7-phosphoniatricyclo[3.3.1.13,7]decan-7-yl)ethanoate-κ4 N:N′:O,O′]silver(I)] tetrafluoroborate], {[Ag(C9H16N3O2P)]BF4} n , was synthesized in an aqueous solution of zwitterionic 2-(1,3,5-triaza-7-phosphoniatricyclo[3.3.1.13,7]decan-7-yl)ethanoate (L) and AgBF4 with exclusion of light at room temperature. The colourless and light-insensitive CP crystallized in the monoclinic space group Cc. The asymmetric unit consists of an AgI cation, the zwitterionic L ligand and a BF4 − counter-ion. Each AgI ion is coordinated by two carboxylate oxygen atoms in a chelating coordination mode, as well as one of the nitrogen atoms of two neighbouring L ligands. The crystal structure of the CP was classified as a unique three-dimensional arrangement. The CP was also characterized in aqueous solutions by multinuclear NMR and HRMS spectroscopies and elemental analysis.

APA, Harvard, Vancouver, ISO, and other styles

18

Zoidis, Grigoris, María Isabel Loza, and Marco Catto. "Design, Synthesis and 5-HT1A Binding Affinity of N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)tricyclo[3.3.1.13,7]decan-1-amine and N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)-3,5-dimethyl-tricylo[3.3.1.13,7]decan-1-amine." Molbank 2022, no. 1 (March 10, 2022): M1353. http://dx.doi.org/10.3390/m1353.

Full text

Abstract:

Based on previously highlighted structural features, the development of highly selective 5-HT1A receptor inhibitors is closely linked to the incorporation of a 4-alkyl-1-arylpiperazine scaffold on them. In this paper, we present the synthesis of two new compounds bearing the 2-MeO-Ph-piperazine moiety linked via a three carbon atom linker to the amine group of 1-adamantanamine and memantine, respectively. Both were tested for their binding affinity against 5-HT1A receptor. N-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)tricyclo[3.3.1.13,7]decan-1-amine fumarate (8) and N-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-3,5-dimethyl-tricylo[3.3.1.13,7]decan-1-amine fumarate (10) proved to be highly selective ligands towards 5-HT1A receptor with a binding constant of 1.2 nM and 21.3 nM, respectively, while 5-carboxamidotriptamine (5-CT) (2) was used as an internal standard for this assay with a measured Ki = 0.5 nM.

APA, Harvard, Vancouver, ISO, and other styles

19

Ogino, Toshio, Kazuyuki Awano, and Yoshimasa Fukazawa. "Novel acid-catalysed rearrangement of 4-substituted pentacyclo[5.3.0.02,5.03,9.04,8]decan-6-ones; X-ray molecular structure of 1-phenylpentacyclo[4.4.0.02,10.03,8.05,7]decan-4-one." Journal of the Chemical Society, Perkin Transactions 2, no. 11 (1990): 1735. http://dx.doi.org/10.1039/p29900001735.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Bravo, Pierfrancesco, Gluseppe Resnatl, Florenza Vlanl, and Alberto Arnone. "Synthesis of the (4S, 5R)-5-hydroxy-decan-4-olide (L-factor) and of the (R)-decan-4-olide from a chiral sulphoxide." Tetrahedron 43, no. 20 (January 1987): 4635–47. http://dx.doi.org/10.1016/s0040-4020(01)86906-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Lynch, V. M., B. E. Wiechman, and J. C. Gilbert. "Structure of 7-phenylthio-1,4-dioxaspiro[4.5]decan-8-one." Acta Crystallographica Section C Crystal Structure Communications 43, no. 2 (February 15, 1987): 378–80. http://dx.doi.org/10.1107/s0108270187095696.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Natarajan, S., V. Sudha Priya, V. Vijayakumar, J. Suresh, and P. L. Nilantha Lakshman. "4,8,9,10-Tetrakis(4-fluorophenyl)-1,3-diazatricyclo[3.3.1.1]decan-6-one." Acta Crystallographica Section E Structure Reports Online 65, no. 7 (June 10, 2009): o1530. http://dx.doi.org/10.1107/s160053680902090x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Kadentsev, V. I., B. I. Maksimova, O. S. Chizhov, and L. A. Yanovskaya. "Comparative study of the electron impact decomposition of 5,5,9-trimethyl-1-oxaspiro[4.5]decan-2-one and 5,5,9-trimethyl-1-oxabicyclo[4.4]decan-2-one." Bulletin of the Academy of Sciences of the USSR Division of Chemical Science 38, no. 4 (April 1989): 874–76. http://dx.doi.org/10.1007/bf00953314.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Wang, Peng-Peng, Qiu-Yue Lin, and Fan Zhang. "4-(3,5-Dioxo-10-oxa-4-azatricyclo[5.2.1.02,6]decan-4-yl)-10-oxa-4-azatricyclo[5.2.1.02,6]decane-3,5-dione." Acta Crystallographica Section E Structure Reports Online 68, no. 2 (January 14, 2012): o381. http://dx.doi.org/10.1107/s1600536812000542.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Weise, Teresa, Marco Kai, Anja Gummesson, Armin Troeger, Stephan von Reuß, Silvia Piepenborn, Francine Kosterka, et al. "Volatile organic compounds produced by the phytopathogenic bacteriumXanthomonas campestrispv.vesicatoria85-10." Beilstein Journal of Organic Chemistry 8 (April 17, 2012): 579–96. http://dx.doi.org/10.3762/bjoc.8.65.

Full text

Abstract:

Xanthomonas campestrisis a phytopathogenic bacterium and causes many diseases of agricultural relevance. Volatiles were shown to be important in inter- and intraorganismic attraction and defense reactions. Recently it became apparent that also bacteria emit a plethora of volatiles, which influence other organisms such as invertebrates, plants and fungi. As a first step to study volatile-based bacterial–plant interactions, the emission profile ofXanthomonas c.pv.vesicatoria85-10 was determined by using GC/MS and PTR–MS techniques. More than 50 compounds were emitted by this species, the majority comprising ketones and methylketones. The structure of the dominant compound, 10-methylundecan-2-one, was assigned on the basis of its analytical data, obtained by GC/MS and verified by comparison of these data with those of a synthetic reference sample. Application of commercially available decan-2-one, undecan-2-one, dodecan-2-one, and the newly synthesized 10-methylundecan-2-one in bi-partite Petri dish bioassays revealed growth promotions in low quantities (0.01 to 10 μmol), whereas decan-2-one at 100 μmol caused growth inhibitions of the fungusRhizoctonia solani. Volatile emission profiles of the bacteria were different for growth on media (nutrient broth) with or without glucose.

APA, Harvard, Vancouver, ISO, and other styles

26

Somanathan, R., I. A. Rivero, G. I. Nuñez, and L. H. Hellberg. "Convenient Synthesis of 1-Oxa-3,8-diazaspiro [4,5] Decan-2-ones." Synthetic Communications 24, no. 10 (May 1994): 1483–87. http://dx.doi.org/10.1080/00397919408011753.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kumaran, D., M. N. Ponnuswamy, G. Shanmugam, K. Sivakumar, and H. K. Fun. "Structure and conformation of two new diazabicyclo[5.3.0]decan-2-ones." Acta Crystallographica Section A Foundations of Crystallography 52, a1 (August 8, 1996): C269. http://dx.doi.org/10.1107/s0108767396088733.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Ha, Kwang. "4-Nitro-2-{[(tricyclo[3.3.1.13,7]decan-1-yl)iminiumyl]methyl}phenolate." Acta Crystallographica Section E Structure Reports Online 68, no. 4 (March 28, 2012): o1221. http://dx.doi.org/10.1107/s1600536812012597.

Full text

Abstract:

The title compound, C17H20N2O3, is a Schiff base, which is found as a zwitterion in the solid state. The geometry around the iminium N atom indicatessp2-hybridization. The zwitterion shows a strong intramolecular N—H...O hydrogen-bond interaction between the iminium N atom and the phenolate O atom.

APA, Harvard, Vancouver, ISO, and other styles

29

Parvez, Masood, Govindaraji Senthil, and Veejendra K. Yadav. "7-Phenyl-1-oxa-4-thiaspiro[4.5]decan-7-ol stereoisomers." Acta Crystallographica Section C Crystal Structure Communications 57, no. 5 (May 15, 2001): 577–79. http://dx.doi.org/10.1107/s0108270101001573.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Biswas, G., A. C. Gomes, A. K. Pal, A. Bera, K. L. Ghatak, U. C. Haider, and A. Banerjee. "Crystal structure of trans-9,10-dichlorotricyclo [3.3.2.01,5]decan-2-one, C10H12Cl2O." Zeitschrift für Kristallographie - New Crystal Structures 212, no. 1 (December 1, 1997): 265–66. http://dx.doi.org/10.1524/ncrs.1997.212.1.265.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Arias, M. S., E. Galvez, and B. Rico. "Conformational study of 8-phenethyl-8-azabicyclo[4.3.1]decan-10α-OL." Journal of Molecular Structure 218 (March 1990): 93–97. http://dx.doi.org/10.1016/0022-2860(90)80249-j.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Adam, Waldemar, Ernst Schmidt, Eva-Maria Peters, Karl Peters, and Hans-Georg von Schnering. "Kristallstruktur von 2,4,5,7,9,10-Hexaoxa-1,3,6,8-tetraphenyltricyclo[6.2.0.03,6]decan: Ein authentisches Bisdioxetan." Angewandte Chemie 95, no. 7 (January 17, 2006): 566–67. http://dx.doi.org/10.1002/ange.19830950719.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Walker, Ashley, Craig M. Forsyth, and Patrick Perlmutter. "2-(10′,10′-Dimethyl-3′-sulfanylidene-4′-azatricyclo[5.2.1.01,5]decan-2′-yl)-10,10-dimethyl-4-azatricyclo[5.2.1.01,5]decane-3-thione." Acta Crystallographica Section E Structure Reports Online 69, no. 8 (July 20, 2013): o1282. http://dx.doi.org/10.1107/s1600536813019211.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

OGINO, T., K. AWANO, and Y. FUKAZAWA. "ChemInform Abstract: Novel Acid-Catalysed Rearrangement of 4-Substituted Pentacyclo(5.3.0. 02,5.03,9.04,8)decan-6-ones (IV). X-Ray Molecular Structure of 1- Phenylpentacyclo(4.4.0.02,10.03,8.05,7)decan-4-one." ChemInform 22, no. 7 (August 23, 2010): no. http://dx.doi.org/10.1002/chin.199107113.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Guillon, Jean, Solène Savrimoutou, Sandra Rubio, Stéphane Moreau, Noël Pinaud, Mathieu Marchivie, and Vanessa Desplat. "1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, Crystal Structure and Anti-Leukemic Activity." Molbank 2020, no. 1 (January 29, 2020): M1113. http://dx.doi.org/10.3390/m1113.

Full text

Abstract:

1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one has been successfully synthesized via a multi-step pathway starting from 2-nitroaniline. Structure characterization of this original pyrrolo[1,2-a]quinoxaline derivative was achieved by FT-IR, 1H-NMR, 13C-NMR, X-Ray and HRMS spectral analysis. This title compound shows interesting cytotoxic potential against several human leukemia cell lines (K562, HL60, and U937 cells).

APA, Harvard, Vancouver, ISO, and other styles

36

S. R. Subba Rao, G., and Sadagopan Raghavan. "Synthesis of 5,5-Dimethyl-7-methoxy-4-oxatricyclo[4,3,1,03,7]decan-2-ones." HETEROCYCLES 37, no. 1 (1994): 131. http://dx.doi.org/10.3987/com-93-s4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Feliu, Lidia, David Font, Roger Soley, Julien Tailhades, Jean Martinez, and Muriel Amblard. "Microwave-enhanced solid phase synthesis of 1,4,8-triazaspiro[4.5]decan-2-ones." Arkivoc 2007, no. 4 (August 26, 2006): 65–72. http://dx.doi.org/10.3998/ark.5550190.0008.406.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Akkurt, Mehmet, Şerife Pınar Yalçın, Nalan Terzioğlu Klip, and Orhan Büyükgüngör. "8-Methyl-4-morpholinoethyl-1-thia-4-azaspiro[4.5]decan-3-one." Acta Crystallographica Section E Structure Reports Online 64, no. 8 (July 23, 2008): o1572—o1573. http://dx.doi.org/10.1107/s1600536808022459.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Zolotarev, R. N., and V. V. Razin. "Synthesis of 2-Phenyl-3-oxa-5-azatricyclo[4.4.0.02,7]decan-4-one." Russian Journal of Organic Chemistry 39, no. 12 (December 2003): 1716–18. http://dx.doi.org/10.1023/b:rujo.0000019733.86386.70.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Vlasova, L. I., S. S. Faizullina, A. N. Lobov, O. S. Kukovinets, and V. A. Dokichev. "Synthesis of 5-(Benzylamino)-exo-3-azatricyclo-[5.2.1.02,6]decan-4-one derivatives." Russian Journal of Organic Chemistry 52, no. 12 (December 2016): 1792–96. http://dx.doi.org/10.1134/s1070428016120149.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Neuenfeldt, Patrícia D., Bruna B. Drawanz, Wilson Cunico, Edward R. T. Tiekink, James L. Wardell, and Solange M. S. V. Wardell. "4-(Pyrimidin-2-yl)-1-thia-4-azaspiro[4.5]decan-3-one." Acta Crystallographica Section E Structure Reports Online 65, no. 12 (November 25, 2009): o3190—o3191. http://dx.doi.org/10.1107/s1600536809049460.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Tsai, Yow-Fu, Yu-Ting Su, and Chia-Her Lin. "(2S)-2-(3-Oxo-1,4-dioxaspiro[4.5]decan-2-yl)ethanoic acid." Acta Crystallographica Section E Structure Reports Online 64, no. 5 (April 30, 2008): o939. http://dx.doi.org/10.1107/s160053680801146x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Anastasis, Panayiotis, Ray Duffin, Victor Matassa, and Karl H. Overton. "Transannular cyclisation products of a 7-ethyl idenebicyclo[3.3.2]decan-3-one." Journal of the Chemical Society, Perkin Transactions 1, no. 5 (1991): 1221. http://dx.doi.org/10.1039/p19910001221.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Park, K., D. C. Swenson, W. J. Scott, and D. F. Wiemer. "(1β,5α,6β)-10,10-(1,2-Ethylenedioxy)-1,5-dimethylbicyclo[4.4.0]decan-4-one." Acta Crystallographica Section C Crystal Structure Communications 51, no. 2 (February 15, 1995): 268–70. http://dx.doi.org/10.1107/s0108270194008759.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Fun, Hoong-Kun, Tze Shyang Chia, Poovan Shanmugavelan, and Alagusundaram Ponnuswamy. "4-Benzyl-8-phenyl-1-thia-4-azaspiro[4.5]decan-3-one." Acta Crystallographica Section E Structure Reports Online 68, no. 5 (April 18, 2012): o1438. http://dx.doi.org/10.1107/s1600536812015358.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Dzierżawska-Majewska, Agnieszka, Janina Karolak-Wojciechowska, and Jolanta Obniska. "4-[(1,3-Dioxo-2-azaspiro[4.5]decan-2-yl)amino]benzoic acid." Acta Crystallographica Section E Structure Reports Online 62, no. 3 (February 8, 2006): o931—o932. http://dx.doi.org/10.1107/s1600536806003515.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Tinant, B., J. P. Declercq, M. van Meerssche, Ph Picard, J. Moulines, and M. Lecoustre. "Trans 8-Tert-Butyl-2-Oxaspiro [4. 5] Decan-3-One C13H22O2." Bulletin des Sociétés Chimiques Belges 96, no. 7 (September 1, 2010): 521–24. http://dx.doi.org/10.1002/bscb.19870960706.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Danieli, Bruno, Federico Maria Rubino, and Luigi Zecca. "Electron impact mass spectrometry of substituted 1,3,8-triazaspiro[4,5]decan-4-ones." Biological Mass Spectrometry 18, no. 11 (November 1989): 1000–1004. http://dx.doi.org/10.1002/bms.1200181108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Aboul-Enein, Mohamed Nabil, Aida Abdel Sattar El-Azzouny, Ola Ahmed Saleh, Kamilia Mahmoud Amin, Yousreya Ali Maklad, and Rasha Mohamed Hassan. "Synthesis and Anticonvulsant Activity of Substituted-1,3-diazaspiro[4.5]decan-4-ones." Archiv der Pharmazie 348, no. 8 (May 29, 2015): 575–88. http://dx.doi.org/10.1002/ardp.201500092.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Schmidt, Kerstin, and Paul Margaretha. "Photochemistry of Spiro[6H-[1,3]Oxathiin-2,2′-tricyclo[3.3.1.13,7]decan]- 6-one." Helvetica Chimica Acta 87, no. 7 (July 2004): 1906–11. http://dx.doi.org/10.1002/hlca.200490169.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!